To investigate the quality of glycaemic control that is achievable in diabetic patients with persistent proteinuria and asymptomatic but declining renal function three matched groups of patients were studied. The first comprised diabetics with proteinuria receiving continuous subcutaneous insulin infusion; the second, diabetics without proteinuria receiving continuous subcutaneous insulin infusion; and the third, diabetics with proteinuria receiving conventional insulin treatment.
dysfunction is important because correcting abnormalities in metabolic control may slow the development of microangiopathy. Continuous subcutaneous insulin infusion can provide long periods of nearly normal glycaemia in insulin dependent diabetics without renal impairment, and in diabetics with early functional abnormalities of the kidney (testing with Albustix for microalbuminuria yields negative results) it rapidly reduces urinary rates of excretion of albumin and may return them to normal.' In 1983 we showed, however, that in a small group of diabetics with more advanced nephropathy (testing with Albustix for proteinuria yields persistently positive results) up to two years of continuous subcutaneous insulin infusion did not appreciably slow the decline in the glomerular filtration rate or reduce either proteinuria or the rate of rise in plasma creatinine concentrations. 2 Although glycaemic control was appreciably better with continuous subcutaneous infusion of insulin than with conventional insulin treatment, failure to influence the progression of nephropathy may have resulted, at least in part, from difficulty in achieving the same degree of strict control as in diabetics who do not have proteinuria and are treated with continuous subcutaneous insulin infusion.
Renal failure also has complex metabolic consequences. Insulin metabolism is altered, and daily requirements may fall considerably in diabetics treated with insulin. Moreover, patients with renal failure but without diabetes may develop intolerance of glucose de novo,' mainly, but not exclusively, because of an increased resistance of tissue to the effects of insulin of "post receptor" origin. 6 Although the management of patients with renal failure but previously without diabetes has recently been reviewed,7 little attention has been given to the quality of glycaemic control that is now possible in diabetics with proteinuria but only mild renal impairment.
These reasons for suspecting difficulty in achieving strict glycaemic control in proteinuric diabetics during optimised regimens such as continuous subcutaneous insulin infusion led us to measure such derangements by measuring a number of variables of control in three groups of patients. We therefore compared the quality of glycaemic control achieved with continuous subcutaneous insulin infusion in diabetics with and without proteinuria and with conventional insulin treatment in diabetics with proteinuria.
Patients and methods Table I shows the clinical characteristics of the three groups of patients studied. Group 1 comprised six insulin dependent diabetics with established diabetic nephropathy and persistent proteinuria (as shown by testing with Albustix) being treated with continuous subcutaneous infusion of insulin; group 2 comprised six insulin dependent diabetics with no evidence of diabetic nephropathy (repeatedly negative results on Albustix testing for proteinuria and normal plasma creatinine concentrations and glomerular filtration rates), being treated with continuous subcutaneous infusion of insulin; and group 3 comprised six patients with established diabetic nephropathy and persistent proteinuria who were all receiving twice daily injections of insulin. The groups were matched for age, sex, and duration of diabetes; in all patients plasma C peptide concentrations were below 0 2 nmol/l six minutes after administration of 1 mg glucagon intravenously.8 The patients were studied for 12 to 30 months from 1981 to 1983.
CHARACTERISTICS OF PATIENTS
In patients with nephropathy, non-diabetic causes of renal damage were excluded on clinical and biochemical grounds (confirmed in three patients (cases 3, 4, and 16) by histological findings after renal biopsy). None of the patients with nephropathy had symptoms from their renal failure, and in particular none had reached the stage of nausea and vomiting; their appetites were normal. Table II shows the known duration of proteinuria and the mean glomerular filtration rate during the study (five measurements were taken at intervals of three to six months) in patients in groups 1 and 3. The mean duration of persistent proteinuria was significantly longer in patients receiving continuous subcutaneous insulin infusion than in those receiving conventional insulin treatment. The difference in mean glomerular filtration rate between the two groups did not reach significance; one patient in group 3 still had a raised but declining glomerular filtration rate after more than three years' proteinuria.
No special advice on diet had been given to the patients with proteinuria, and dietary assessment showed no significant difference between the groups in mean dietary intake of energy or in the pro Patients treated with continuous subcutaneous insulin infusion also estimated fasting capillary blood glucose concentrations with Dextrostix (Ames) on 10 consecutive days at home, at a randomly selected time during the period of study. The mean (SD) of these 10 recordings was estimated in each patient as a measure of day to day variability of basal (fasting) control of glycaemia.
The incidence of biochemical hypoglycaemia was determined in each of the three groups by calculating the proportion of all plasma glucose concentrations that were lower than an arbitrary value of 3 0 mmol/l (54 mg/100 ml) during the 24 hour periods in hospital. Glomerular filtration rate was estimated after a single injection of disodium edetate labelled with chromium-5112 and corrected for body surface area. Differences within and between means for each group were tested for significance by Student's paired or unpaired t test, on log transformed data if necessary. The study was approved by the Guy's Hospital ethical committee. Results GLYCAEMIC CONTROL Table III shows the variables of glycaemic control in the three groups of patients. The mean daily plasma glucose concentration in patients receiving continuous subcutaneous insulin infusion was significantly higher in those with proteinuria (group 1) than in those without (group 2) (p<0 001), although the mean plasma glucose concentration in patients in group 1 was still significantly lower (p < 0-02) than that in patients with proteinuria receiving conventional insulin treatment (group 3). rABLE iii-Control of glycaemia achieved in diabetics zwith proteitnuria receiving continuous subcutaneous insulin infusion (group 1), in diabetics w-ithout proteinuria receiving continuous subcutaneous insulin infusion (group 2), and in diabetics with proteinuria receiving conventional insulin treatment (group 3)
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The standard deviation and range of plasma glucose concentrations, used to estimate dispersion of values throughout the day, were also significantly greater (p <0 01) in patients in group 1 than in those in group 2, but the greatest variability was in the diabetics with proteinuria who were receiving conventional insulin treatment. The mean M value (table III) in group 1 was significantly higher (p<0 001) than that in group 2 but significantly lower (p < 0 05) than that in group 3.
A trend towards greater day to day variability in patients in group 1 compared with patients in group 2 was shown by the standard deviations of 10 consecutive fasting blood glucose concentrations, but this difference did not reach significance.
The proportion of plasma glucose concentrations below 3-0 mmol,l was significantly smaller in patients in group 1 than in those in group 2 (p<0O05). The smallest proportion was recorded in the diabetics with proteinuria receiving conventional insulin treatment (group 3). for each of the three groups. Fasting values in groups 1 and 2 were similar, but during the day the concentrations were higher in those with proteinuria (group 1), these differences reaching significance at 1200 (p<0 02) and 1800 (p<0 01). Values in patients receiving conventional insulin treatment were higher than those in the two other groups at most times during the 24 hours but particularly during waking hours. Table IV shows the mean daily doses of insulin in the three groups of patients one year after diagnosis and when last seen (14-32 years later). The dose of insulin was significantly reduced over this time in the patients with proteinuria (by 30n, in group 1 (p<0 05) and by 22°in group 3 (p <0-005)) but not in the diabetics without proteinuria. Review of the patients' history of insulin dosage showed that the reduction in dosage had begun shortly after the onset of persistent proteinuria. Table I lists the insulin doses being received by each patient at the end of the study. The mean total daily dose of insulin was slightly, but not significantly, lower in patients in group 1 than in those in group 2 (0 51 (0-19) v 0-62 (0-18) U/kg). When the prandial dose was expressed as a proportion of the total dose, however, it was significantly smaller in patients in group 1 than group 2 (33-0 (4.18)°, v 41 8 (1-33)0°,, (p <0 001)). Figure 2 shows the changes throughout the study in the proportion of the total insulin dose given prandially in groups 1 and 2. The prandial dose was significantly reduced (p<0 05) during the first week in patients in group 1 in response to initial symptomatic diurnal hypoglycaemia that was either recorded in hospital or reported by the patients at home. No such hypoglycaemia was experienced by the patients without proteinuria. Conversion: SI to traditional units-Glucose: 1 mmol/ 18 mg/100 ml.
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Discussion
The results of this study indicate that strict glycaemic control with continuous subcutaneous infusion of insulin in diabetic patients is more difficult to achieve in those who have proteinuria than in those who do not, the mean daily plasma glucose concentration and variation around the daily mean being r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ĩ -j higher in patients with proteinuria. Nevertheless, control with continuous subcutaneous infusion in patients with proteinuria was greatly superior to that achieved in a matched group of diabetics with proteinuria receiving conventional insulin treatment. The observation that glycaemic control induced by continuous subcutaneous insulin infusion was less "tight" is associated with the finding that the ratio of prandial to total insulin dose in these patients was significantly lower (p <0-001) than in the group of patients without proteinuria receiving continuous subcutaneous insulin infusion. This would explain the largely diurnal loss of control in patients with proteinuria that occurred within the first week of treatment with continuous infusion. The insulin dosage was adjusted at that time in response to daytime symptomatic hypoglycaemia, reported in each patient in the group. We do not know whether hypoglycaemia developed in patients with proteinuria because of accompanying autonomic neuropathy or because of therapeutic adrenergic receptor blockade, or both, but we had noted that the patients without proteinuria did not appear to have autonomic neuropathy.
Difficulty in achieving strict glycaemic control in patients with proteinuria, even during intensified insulin regimens, might be expected for several reasons. Firstly, intolerance of carbohydrates, which may develop de novo with advancing renal failure in patients previously not suffering from diabetes,3 may add to the difficulty of achieving nearly normal glucose concentrations in diabetics with renal disease. Peripheral resistance to the effects of insulin appears to be a major factor in the development of this intolerance of glucose and may be largely accounted for by an accompanying defect in postreceptor binding.6 Other mechanisms may also contribute."3 -5 Secondly, loss of insulin removal by the kidneys with advancing kidney disease'6 17 probably chiefly accounts for the increased plasma concentrations of insulin in patients with renal failure who do not have diabetes '8 19 and may also account for diminishing exogenous requirements in diabetics with advancing renal disease. '6 20-25 We confirmed the second of these observations in both of our groups of patients with proteinuria: insulin doses were significantly smaller in both groups at the time of the present study than at one year after diagnosis. The fall in dose is unlikely to have been due to the change from conventional insulin treatment to continuous subcutaneous insulin infusion as no such fall was found (over a mean period of 23 years) in the patients who did not have proteinuria despite their having changed to treatment with continuous subcutaneous insulin infusion between one and two and a half years before the study. In addition, the fall in daily dosages of insulin is also unlikely to have been due to a change from traditional beef insulin to highly purified pork insulin at some stage during the period of treatment. Six of the 12 patients with proteinuria had been treated with highly purified porcine insulin from diagnosis, and one had continued to receive beef insulin of conventional purity. In the patients whose treatment had been changed to highly purified porcine insulin the reduction in dosage of insulin was not temporally related to the change and occurred at a later date, presumably with the onset and progression of nephropathy.
End stage renal failure with accompanying weight loss, debilitation, nausea, and vomiting will clearly contribute to disturbed metabolic control in diabetics, probably as a response to restricted intake of energy. Even patients maintained on adequate nutritional programmes, however, manifest intolerance of carbohydrate in chronic renal failure.26 2 Our patients with proteinuria had not developed symptomatic uraemia, did not complain of anorexia, and consumed diets that did not differ appreciably in total content of energy or in composition from those consumed by the patients without proteinuria.
Patients with renal impairment were selected on the basis that Albustix testing for proteinuria yielded persistently positive results. One such patient, who was receiving conventional insulin treatment, had a mean glomerular filtration rate during the study that was still above the normal range even though she had had proteinuria with a falling glomerular filtration rate for three years. The mean glomerular filtration rate was higher and the duration of known proteinuria appreciably shorter in diabetics with proteinuria receiving conventional insulin treatment than in diabetics with proteinuria receiving continuous subcutaneous insulin infusion. Assuming that nephropathy associated with a low glomerular filtration rate makes control of glycaemia more difficult, this underlines the differences in the ability of the two treatments to control glycaemia.
We conclude that relaxing the administration of prandial insulin in response to diurnal hypoglycaemia accounts for the loss of glycaemic control in diabetics with proteinuria. This does not prove that strict near normoglycaemia is impossible to achieve in these patients (for example, by finer tuning of prandial insulin boosts), but it would appear to support the advice that continuous subcutaneous infusion of insulin ( pretation of the results. Studies have also generally failed to consider the importance of psychosocial stress relative to factors known to be associated with low birth weight, such as social class and cigarette smoking, though there have been notable exceptions.3 Retrospective studies have often allowed the possible bias of results by "effort after meaning," a term that implies that women experiencing an adverse outcome of pregnancy may make a conscious effort to explain this by blaming a particular life event that has happened to them.
Because of these methodological problems in previous studies we carried out a prospective study of an unselected population of women who were interviewed at least twice during pregnancy by a single interviewer (RWN). The number, nature, and subjective effect of any life events were recorded, the outcome of pregnancy defined, and the contribution of social class and cigarette smoking considered. We report here our results.
Patients and methods
The study population was randomly selected from women booking into St Mary's Hospital, Manchester, for their antenatal care. Hospital Activity Analysis showed that 860, of babies of low birth weight were booked deliveries. To avoid language difficulties only women born in the United Kingdom were interviewed, irrespective of racial origin; 95°were white.
Assuming a prevalence of babies of low birth weight of 8-10%' and a prevalence of major life events similar to that recorded in our previous, retrospective study,4 we selected a population of 250 to give a group of about 20 babies of low birth weight (< 2500 g) and, probably, a significant result.
Patients were interviewed at their initial booking visit, at about 30 weeks' gestation, when possible between 37 and 40 weeks' gestation, and shortly after delivery. Age, marital state, husband's occupation, number of people per room (as defined by the Office of Population Censuses and Surveys5) at home, obstetric history, and smoking habit were recorded. The modified life events inventory used in the retrospective study4 was presented at each interview and the experience and timing of any life event during pregnancy noted. Patients were also asked to complete Spielberger's state anxiety index6 according to how they felt "at that moment in the antenatal clinic"; they also completed the index in relation to any major life event experienced according to how they had "felt about it at the time."
The state anxiety index is self administered and contains 20 items, each scored on a scale of 1 to 4. The four categories are: 1, not at all; 2, somewhat; 3, moderately so; and 4, very much so. Half of the
